Royce & Associates LP Inotiv, Inc. Transaction History

Royce & Associates LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$3.27 - $11.04 $166,008 - $560,467	50,767 New	50,767 $555,000
Q2 2022 Aug 04, 2022	SELL	$9.56 - $25.91 $569,776 - $1.54 Million	-59,600 Reduced 45.75%	70,669 $678,000
Q1 2022 May 05, 2022	SELL	$18.52 - $40.41 $92,600 - $202,049	-5,000 Reduced 3.7%	130,269 $3.41 Million
Q4 2021 Feb 07, 2022	SELL	$30.55 - $57.88 $2.3 Million - $4.35 Million	-75,127 Reduced 35.71%	135,269 $5.69 Million
Q3 2021 Nov 10, 2021	SELL	$23.69 - $49.93 $80,546 - $169,762	-3,400 Reduced 1.59%	210,396 $6.15 Million
Q2 2021 Aug 06, 2021	BUY	$18.9 - $31.42 $4.04 Million - $6.72 Million	213,796 New	213,796 $5.7 Million

3.67M

1.1K

21.3K

Ticker NOTV
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 25,594,500
Market Cap $68.6M
Description
Inotiv, Inc. provides drug discovery and development services to the pharmaceutical, chemical, and medical device industries; and sells analytical instruments to the pharmaceutical development and contract research industries. It operates through two segments, Contract Research Services and Research Products. The Contract Research Services segme...

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

Stay updated on Royce & Associates LP with notifications on news.